Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
myelofibrosis
Pharma
With cash dwindling and a loan due, Karyopharm faces default
With a loan due and its cash runway stretching only into next month, Karyopharm Therapeutics is scrambling for a solution.
Kevin Dunleavy
Aug 13, 2026 2:52pm
Karyopharm reports Xpovio miss, FDA filing in separate cancers
Jul 31, 2026 10:00am
Can mixed results gain an expansion for Karyopharm's Xpovio?
Mar 24, 2026 11:56am
Sanofi inks $1.5B deal for Sino Biopharm's novel asset
Mar 4, 2026 3:00am
Bristol Myers' clinical woes deepen with failed Reblozyl ph. 3
Jul 18, 2025 11:28am
JPM25: Incyte plans to turn 'a lot of cards' in 2025, CEO says
Jan 22, 2025 2:38pm
